April 16, 2024

PRISM Market Moves on Tuesday: Intra-Cellular Therapies Soars on Depression Results; Live Nation Down on Antitrust Lawsuit Reports

US equities are trading mostly lower on Tuesday at midday, with the S&P 500 down for a third straight session. Homebuilders, banks, chemicals, industrial metals, energy, airlines, REITs, and utilities are weak. Big tech is mixed with some drag from Tesla ($TSLA) again today. Outperformers include managed care, semis, P&C insurance, healthcare distributors, food/beverages, and… [Read More]
April 15, 2024

FDA Accepts UroGen’s Investigational New Drug Application for Bladder Cancer Treatment

The FDA has accepted UroGen Pharma’s (Nasdaq: URGN) Investigational New Drug (IND) application for UGN-103, a next-generation novel mitomycin-based formulation for low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). UGN-103 uses UroGen’s RTGel® platform technology, a proprietary sustained-release, reverse-thermal hydrogel that can improve the therapeutic profiles of existing drugs. The company’s share price was up 0.13%… [Read More]
April 15, 2024

Corporate Cannabis Changes: Jushi Holdings (JUSHF) Appoints COO

The multi-state cannabis operator and PRISM Cannabis Index company, Jushi Holdings Inc. (JUSHF) has appointed Todd West as its Chief Operating Officer (“COO”), effective April 12, 2024. Bringing over 25 years of operational expertise across retail, manufacturing, and wholesale sectors, including five years in the cannabis industry, Mr. West’s most recent role was as Executive… [Read More]
April 15, 2024

PRISM Market Moves on Monday: Medical Properties Trust Surges; Tesla and Apple Slump

US equities are mixed on Monday at midday, well off best levels after stocks sold off on Friday with all the major indexes down. Investment banks, money center banks, industrial metals, A&D, semi cap equipment, pharma and apparel/accessories are outperforming, while EVs, cloud software, homebuilders and REITs, department stores are weaker. Treasuries are under, the… [Read More]
April 15, 2024

Charles Schwab’s Report is out.. Carl boasts big Metrics

The Charles Schwab Corporation (SCHW) ended its quarter in March 2024, reporting a revenue of $4.74 billion, a 7.4% decrease compared to the same period last year. Its earnings per share (EPS) were at $0.74, in contrast to $0.93 during the same quarter last year. This reported revenue was slightly above the Zacks Consensus Estimate… [Read More]
April 15, 2024

Market Summary: Spike in US Yields as Tech Stocks Decline and Retail Sales Surge

US bond markets reacted sharply on Monday, with yields soaring in response to robust retail sales data, igniting speculation that the Federal Reserve might delay interest rate cuts. This sentiment was exacerbated by preparations for an upcoming surge in bank debt offerings. Treasury yields reached new highs for 2024, notably affecting tech stocks sensitive to… [Read More]
April 13, 2024

Advancing Vaccines for Cancer

Cancer was responsible for nearly 10 million deaths in 2020. Treatments for cancer, which represents a group of complex and diverse diseases, have been in development for more than a century, but most still lack safe and effective therapeutic options. The current standards of care – surgery, radiation, chemotherapy and precision approaches such as immune… [Read More]
April 12, 2024

Solar Innovations Shine: Maxeon’s (MAXN) Performance 7 Panels Lead the Green Revolution

PRISM New Energy Index company, Maxeon Solar Technologies, Ltd. (MAXN), a prominent force in solar innovation and distribution channels worldwide, has once again elevated industry standards with the introduction of its groundbreaking SunPower Performance 7 solar panels tailored for distributed generation (DG) ventures. These Performance 7 panels boast a cutting-edge cell design and circuitry, coupled… [Read More]